The Clinical Development Team at Artios Pharma is responsible for designing and overseeing clinical trials aimed at evaluating the safety and efficacy of novel cancer treatments that target the DNA Damage Response (DDR). Comprised of clinical advisors, consultants, trial managers, and scientists, the team collaborates to ensure the successful execution of clinical protocols, seeks regulatory approvals, and analyzes trial data to advance innovative therapies that improve patient outcomes.
View all